These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 7074604

  • 1. In vitro generation of tumoricidal properties in human alveolar macrophages following interaction with endotoxin.
    Sone S, Moriguchi S, Shimizu E, Ogushi F, Tsubura E.
    Cancer Res; 1982 Jun; 42(6):2227-31. PubMed ID: 7074604
    [Abstract] [Full Text] [Related]

  • 2. Human alveolar macrophages: potentiation of their tumoricidal activity by liposome-encapsulated muramyl dipeptide.
    Sone S, Tsubura E.
    J Immunol; 1982 Sep; 129(3):1313-7. PubMed ID: 7108208
    [Abstract] [Full Text] [Related]

  • 3. Production of a tumor cytolytic factor(s) by activated human alveolar macrophages and its action.
    Sone S, Tachibana K, Ishii K, Ogawara M, Tsubura E.
    Cancer Res; 1984 Feb; 44(2):646-51. PubMed ID: 6692369
    [Abstract] [Full Text] [Related]

  • 4. Lipopolysaccharide (LPS) stimulates fresh human monocytes to lyse actinomycin D-treated WEHI-164 target cells via increased secretion of a monokine similar to tumor necrosis factor.
    Chen AR, McKinnon KP, Koren HS.
    J Immunol; 1985 Dec; 135(6):3978-87. PubMed ID: 3905966
    [Abstract] [Full Text] [Related]

  • 5. Cytotoxicity of human macrophages for tumor cells: enhancement by bacterial lipopolysaccharides (LPS).
    Cameron DJ, Churchill WH.
    J Immunol; 1980 Feb; 124(2):708-12. PubMed ID: 7356710
    [Abstract] [Full Text] [Related]

  • 6. Human alveolar macrophages: wheat germ agglutinin-dependent tumor cell killing.
    Ogawara M, Sone S, Ogura T.
    Jpn J Cancer Res; 1987 Mar; 78(3):288-95. PubMed ID: 3106285
    [Abstract] [Full Text] [Related]

  • 7. The activation of tumoricidal properties in macrophages of endotoxin responder and nonresponder mice by liposome-encapsulated immunomodulators.
    Fogler WE, Talmadge JE, Fidler IJ.
    J Reticuloendothel Soc; 1983 Mar; 33(3):165-74. PubMed ID: 6834360
    [Abstract] [Full Text] [Related]

  • 8. Synergistic activation by lymphokines and muramyl dipeptide of tumoricidal properties in rat alveolar macrophages.
    Sone S, Fidler IJ.
    J Immunol; 1980 Dec; 125(6):2454-60. PubMed ID: 7430635
    [Abstract] [Full Text] [Related]

  • 9. Induction of in vitro tumoricidal activity in alveolar macrophages and monocytes from patients with lung cancer.
    Thomassen MJ, Wiedemann HP, Barna BP, Farmer M, Ahmad M.
    Cancer Res; 1988 Jul 15; 48(14):3949-53. PubMed ID: 2838166
    [Abstract] [Full Text] [Related]

  • 10. Potential value of liposomes containing muramyl dipeptide for augmenting the tumoricidal activity of human alveolar macrophages.
    Sone S, Tachibana K, Shono M, Ogushi F, Tsubura E.
    J Biol Response Mod; 1984 Jul 15; 3(2):185-94. PubMed ID: 6726281
    [Abstract] [Full Text] [Related]

  • 11. Kinetics and function of tumor cytotoxic factor(s) produced by human blood monocytes activated to the tumoricidal state.
    Sone S, Lopez-Berestein G, Fidler IJ.
    J Natl Cancer Inst; 1985 Mar 15; 74(3):583-90. PubMed ID: 3856062
    [Abstract] [Full Text] [Related]

  • 12. Predisposition of [125I]5-iodo-2'-deoxyuridine-labeled normal and neoplastic mouse fibroblasts to lysis by normal macrophages.
    Evans R, Eidlen DM.
    J Natl Cancer Inst; 1983 Nov 15; 71(5):983-9. PubMed ID: 6580500
    [Abstract] [Full Text] [Related]

  • 13. In vivo activation of nude mouse macrophages by human melanoma cells.
    Benomar A, Gerlier D, Doré JF.
    J Natl Cancer Inst; 1987 Jul 15; 79(1):131-6. PubMed ID: 3474441
    [Abstract] [Full Text] [Related]

  • 14. The induction and augmentation of macrophage tumoricidal responses by platelet-activating factor.
    Howard AD, Erickson KL.
    Cell Immunol; 1995 Aug 15; 164(1):105-12. PubMed ID: 7634340
    [Abstract] [Full Text] [Related]

  • 15. Efficient generation of autologous peripheral blood-derived cytotoxic T lymphocytes against poorly immunogenic human tumors using recombinant CD80-adenovirus together with interleukin 12 and interleukin 2.
    Mogi S, Ebata T, Setoguchi Y, Fujime M, Heike Y, Kohsaka T, Yagita H, Okumura K, Azuma M.
    Clin Cancer Res; 1998 Mar 15; 4(3):713-20. PubMed ID: 9533541
    [Abstract] [Full Text] [Related]

  • 16. IL-2 enhances standard IFNgamma/LPS activation of macrophage cytotoxicity to human ovarian carcinoma in vitro: a potential for adoptive cellular immunotherapy.
    Han X, Wilbanks GD, Devaja O, Ruperelia V, Raju KS.
    Gynecol Oncol; 1999 Nov 15; 75(2):198-210. PubMed ID: 10525372
    [Abstract] [Full Text] [Related]

  • 17. Rat alveolar macrophages are susceptible to activation by free and liposome-encapsulated lymphokines.
    Sone S, Poste G, Fidler IJ.
    J Immunol; 1980 May 15; 124(5):2197-202. PubMed ID: 7365253
    [Abstract] [Full Text] [Related]

  • 18. Tumor cytotoxicity of rat alveolar macrophages activated in vitro by endotoxin.
    Sone S, Fidler IJ.
    J Reticuloendothel Soc; 1980 Mar 15; 27(3):269-79. PubMed ID: 7365733
    [No Abstract] [Full Text] [Related]

  • 19. Spontaneous tumor cell killing by human blood monocytes and human peritoneal macrophages: lack of alteration by endotoxin or quenchers of reactive oxygen species.
    Weinberg JB, Haney AF.
    J Natl Cancer Inst; 1983 Jun 15; 70(6):1005-10. PubMed ID: 6574267
    [Abstract] [Full Text] [Related]

  • 20. Cytotoxic activity of human pulmonary alveolar macrophages.
    Kan-Mitchell J, Hengst JC, Kempf RA, Rothbart RK, Simons SM, Brooker AS, Kortes VL, Mitchell MS.
    Cancer Res; 1985 Jan 15; 45(1):453-8. PubMed ID: 3965151
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.